4
Changes in Ownership
CytomX Therapeutics, Inc. Filed Acc 0001140361-16-080947
Options or other derivatives
- CSO, Head Res.&Non-Clin. Dev. acquired 48,368 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Kavanaugh William Michael CSO, Head Res.&Non-Clin. Dev. | 2016-09-26 | Grant or award · Stock Option (Right to Buy) | +48,368 | 48,368 | D | ||
Loading xslF345X03/doc1.xml…